PsiThera

PsiThera is a biotechnology company pioneering a physics-driven approach to drug design through its proprietary QUAISAR computational platform. Spun out of Roivant Sciences in 2022, the company combines quantum physics-based simulations, machine learning, and in-house high-performance supercomputing with in-house experimental biology and chemistry to design novel small molecule therapeutics targeting previously intractable proteins. PsiThera's integrated approach spans the full drug discovery lifecycle, from computational design to laboratory validation, with a focus on immune system diseases with high unmet medical need.